Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Jian Teng; Seyedali Hejazi; Lotte Hiddingh; Litia Carvalho; Mark De Gooijer; Hiroaki Wakimoto; Marco Barazas; Marie Tannous; Andrew S. Chi; David P. Noske; Pieter Wesseling; Thomas Wurdinger; Tracy T. Batchelor; Bakhos A. Tannous

doi:10.1093/neuonc/noaa166

Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Jian Teng, Seyedali Hejazi, Lotte Hiddingh, Litia Carvalho, Mark De Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, Andrew S. Chi, David P. Noske, Pieter Wesseling, Thomas Wurdinger, Tracy T. Batchelor, Bakhos A. Tannous

Research related

Research output: Contribution to journal › Comment/debate

Abstract

The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

Original language	English
Pages (from-to)	1894
Number of pages	1
Journal	Neuro-Oncology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1093/neuonc/noaa166
Publication status	Published - 1 Dec 2020

Access to Document

10.1093/neuonc/noaa166

Cite this

Teng, J., Hejazi, S., Hiddingh, L., Carvalho, L., De Gooijer, M., Wakimoto, H., Barazas, M., Tannous, M., Chi, A. S., Noske, D. P., Wesseling, P., Wurdinger, T., Batchelor, T. T., & Tannous, B. A. (2020). Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype. Neuro-Oncology, 22(12), 1894. https://doi.org/10.1093/neuonc/noaa166

@article{6d80a2a979a94fcfb6900a32a2c1eccf,

title = "Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype",

abstract = "The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).",

author = "Jian Teng and Seyedali Hejazi and Lotte Hiddingh and Litia Carvalho and {De Gooijer}, Mark and Hiroaki Wakimoto and Marco Barazas and Marie Tannous and Chi, {Andrew S.} and Noske, {David P.} and Pieter Wesseling and Thomas Wurdinger and Batchelor, {Tracy T.} and Tannous, {Bakhos A.}",

year = "2020",

month = dec,

day = "1",

doi = "10.1093/neuonc/noaa166",

language = "English",

volume = "22",

pages = "1894",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

Teng, J, Hejazi, S, Hiddingh, L, Carvalho, L, De Gooijer, M, Wakimoto, H, Barazas, M, Tannous, M, Chi, AS, Noske, DP, Wesseling, P, Wurdinger, T, Batchelor, TT & Tannous, BA 2020, 'Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype', Neuro-Oncology, vol. 22, no. 12, pp. 1894. https://doi.org/10.1093/neuonc/noaa166

TY - JOUR

T1 - Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

AU - Teng, Jian

AU - Hejazi, Seyedali

AU - Hiddingh, Lotte

AU - Carvalho, Litia

AU - De Gooijer, Mark

AU - Wakimoto, Hiroaki

AU - Barazas, Marco

AU - Tannous, Marie

AU - Chi, Andrew S.

AU - Noske, David P.

AU - Wesseling, Pieter

AU - Wurdinger, Thomas

AU - Batchelor, Tracy T.

AU - Tannous, Bakhos A.

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

AB - The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

U2 - 10.1093/neuonc/noaa166

DO - 10.1093/neuonc/noaa166

M3 - Comment/debate

C2 - 33112953

AN - SCOPUS:85098741966

SN - 1522-8517

VL - 22

SP - 1894

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 12

ER -

Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Abstract

Access to Document

Fingerprint

Cite this